PMC:7600245 / 92298-92397 JSONTXT

{"project":"LitCovid-PD-MONDO","denotations":[{"id":"T425","span":{"begin":88,"end":96},"obj":"Disease"}],"attributes":[{"id":"A425","pred":"mondo_id","subj":"T425","obj":"http://purl.obolibrary.org/obo/MONDO_0005091"}],"text":"EIDD-2801 is an orally bioavailable nucleoside derivative that is under development for SARS-CoV-2."}

{"project":"LitCovid-PD-CHEBI","denotations":[{"id":"T607","span":{"begin":36,"end":46},"obj":"Chemical"}],"attributes":[{"id":"A97342","pred":"chebi_id","subj":"T607","obj":"http://purl.obolibrary.org/obo/CHEBI_33838"}],"text":"EIDD-2801 is an orally bioavailable nucleoside derivative that is under development for SARS-CoV-2."}

{"project":"LitCovid-sentences","denotations":[{"id":"T745","span":{"begin":0,"end":99},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"EIDD-2801 is an orally bioavailable nucleoside derivative that is under development for SARS-CoV-2."}

{"project":"LitCovid-PubTator","denotations":[{"id":"3983","span":{"begin":88,"end":98},"obj":"Species"},{"id":"3988","span":{"begin":36,"end":46},"obj":"Chemical"}],"attributes":[{"id":"A3983","pred":"tao:has_database_id","subj":"3983","obj":"Tax:2697049"},{"id":"A3988","pred":"tao:has_database_id","subj":"3988","obj":"MESH:D009705"}],"namespaces":[{"prefix":"Tax","uri":"https://www.ncbi.nlm.nih.gov/taxonomy/"},{"prefix":"MESH","uri":"https://id.nlm.nih.gov/mesh/"},{"prefix":"Gene","uri":"https://www.ncbi.nlm.nih.gov/gene/"},{"prefix":"CVCL","uri":"https://web.expasy.org/cellosaurus/CVCL_"}],"text":"EIDD-2801 is an orally bioavailable nucleoside derivative that is under development for SARS-CoV-2."}